Results 61 to 70 of about 423,580 (268)
Peripheral neuropathy in prediabetes and the metabolic syndrome
Journal of Diabetes Investigation, 2017 Peripheral neuropathy is a major cause of disability worldwide. Diabetes is the most common cause of neuropathy, accounting for 50% of cases. Over half of people with diabetes develop neuropathy, and diabetic peripheral neuropathy (DPN) is a major cause ...
A. Stino, A. G. Smith
semanticscholar +1 more source
Evidence from web-based dietary search patterns to the role of B12 deficiency in chronic pain [PDF]
, 2017 Profound vitamin B12 deficiency is a known cause of disease, but the role of low or intermediate levels of B12 in the development of neuropathy and other neuropsychiatric symptoms as well as the relationship of eating meat and B12 levels is unclear.
arxiv +1 more source
Galectin-1 and galectin-3 as key molecules for peripheral nerve degeneration and regeneration
AIMS Molecular Science, 2016 There is growing evidence that galectin-1 (GAL-1) and galectin-3 (GAL-3) are involved in the process of axonal regeneration after injury and the pathogenesis of peripheral neuropathies, but the precise roles of these galectins in the peripheral nervous ...
Hideji Yako +8 more
doaj +1 more source
Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice
Scientific Reports, 2016 Male C57BL/6J mice raised on high fat diet (HFD) become prediabetic and develop insulin resistance and sensory neuropathy. The same mice given low doses of streptozotocin are a model of type 2 diabetes (T2D), developing hyperglycemia, severe insulin ...
Samuel A. J. Trammell +9 more
semanticscholar +1 more source
Journal of the Peripheral Nervous System, 2001 The occurrence of a peripheral neuropathy (PN) in association with a monoclonal gammopathy is quite common and suggests that monoclonal proteins may play a pathogenetic role in peripheral nervous system damage. In fact, paraproteinemic PN constitute an heterogeneous group of disorders related to various pathogenetic factors, and the histopathologic ...
openaire +3 more sources
Pain, 2016 Disabling neuropathic pain (NeuP) is a common sequel of diabetic peripheral neuropathy (DPN). We aimed to characterise the sensory phenotype of patients with and without NeuP, assess screening tools for NeuP, and relate DPN severity to NeuP.
Andreas C Themistocleous +8 more
semanticscholar +1 more source
Medicine, 2006 Diabetic polyneuropathy affects 30–50% of patients with diabetes mellitus. It encompasses several neuropathic syndromes, the commonest being distal symmetrical polyneuropathy or ‘diabetic peripheral neuropathy’ (DPN). Risk factors for DPN include poor glycaemic control and drivers of macrovascular disease including hypertension.
openaire +2 more sources
Diabetes Care, 2007 Perspectives on the News commentaries are now part of a new, free monthly CME activity. The Mount Sinai School of Medicine, New York, New York, is designating this activity for 2.0 AMA PRA Category 1 credits. If you wish to participate, review this article and visit www.diabetes.procampus.net to complete a posttest and receive a certificate.
openaire +4 more sources
Frontiers in Pharmacology, 2018 Background: Gout is the most common inflammatory arthritis worldwide. It is a painful inflammatory disease induced by the deposition of monosodium urate (MSU) crystals in the joints and peri-articular tissues.
Victor Fattori +11 more
doaj +1 more source
Acta oncologica, 2019 Background: Oxaliplatin, combined with capecitabine (CAPOX) or infused 5-fluorouracil (FOLFOX), is standard of care in the adjuvant treatment of colorectal cancer (CRC). Prospective data on prevalence of oxaliplatin induced acute and long-term neuropathy
L. Soveri +5 more
semanticscholar +1 more source